Open AccessHigh-Throughput Genotyping of Oncogenic Human Papilloma Viruses with MALDI-TOF Mass Spectrometry
Author(s) -
Anna SöderlundStrand,
Joakim Dillner,
Joyce Carlson
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.092627
Subject(s) - genotyping , concordance , cervical intraepithelial neoplasia , cervical cancer , multiplex , genotype , cervical screening , multiplex polymerase chain reaction , human papillomavirus , mass spectrometry , throughput , human papilloma virus , virology , medicine , oncology , biology , cancer , polymerase chain reaction , chemistry , chromatography , bioinformatics , genetics , gene , computer science , wireless , telecommunications
Human papilloma virus (HPV) is the major cause of cervical cancer. Use of HPV genotyping in cervical screening programs and for monitoring the effectiveness of HPV vaccination programs requires access to economical, high-throughput technology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom